Biocon LimitedNSE: BIOCON

Press Release Dec 22 2023

· Issued by Biocon Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-dec-22-2023-3

Biocon Limited has informed the Exchange regarding a press release dated December 22, 2023, titled "Biocon Biologics Partners with Sandoz for the Distribution of Adalimumab BS Subcutaneous Injection [FKB]" in Japan".

View Attachment

6ix hasn’t read this filing yet.

Biocon Limited on 6ix

Earlier from Biocon

Later from Biocon

All Biocon news releases